Meeting on the Med 2021 | Advancing cell therapy in oncology

Filippo Petti, CEO/CFO, Celyad Oncology, Mont-Saint-Guibert, Belgium, summarizes the topics discussed during a panel session on novel cell therapy approaches for oncology at the Cell & Gene Meeting on the Mediterranean 2021 virtual conference. He discusses the importance of building a good manufacturing process in order to deliver novel therapeutics for solid tumor indications, as well as the future commercialization of these therapies, which he believes could reach a similar market presence to other off-the-shelf biological therapies in the future. This interview took place during the Cell & Gene Meeting on the Mediterranean 2021 virtual conference.